Search research articles
Contact Us
Filters
Showing results (51-60 of 112) with videos related to
Page
of 12
Sort By:
Biorxiv : the Preprint Server for Biology
|
December 19, 2025
The N-terminal region of malaria vaccine candidate <i>Plasmodium falciparum</i> asparagine-rich merozoite antigen is immunodominant and targeted by polyreactive antibodies
Rolando Garza, Jeffrey M Marchioni, Jared D Honeycutt, et al.
Journal of Virology
|
July 12, 2013
Residue-level prediction of HIV-1 antibody epitopes based on neutralization of diverse viral strains
Gwo-Yu Chuang, Priyamvada Acharya, Stephen D Schmidt, et al.
Structure (London, England : 1993)
|
March 17, 2023
Cryo-EM structures of anti-malarial antibody L9 with circumsporozoite protein reveal trimeric L9 association and complete 27-residue epitope
Prabhanshu Tripathi, Michael F Bender, Haotian Lei, et al.
Journal of Virology
|
May 25, 2012
A short segment of the HIV-1 gp120 V1/V2 region is a major determinant of resistance to V1/V2 neutralizing antibodies
Nicole A Doria-Rose, Ivelin Georgiev, Sijy O'Dell, et al.
Cell Reports. Medicine
|
May 23, 2024
Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus
Kristina R Edwards, Karina Schmidt, Leah J Homad, et al.
Immunity
|
October 14, 2020
HIV-1 VRC01 Germline-Targeting Immunogens Select Distinct Epitope-Specific B Cell Receptors
Yu-Ru Lin, K Rachael Parks, Connor Weidle, et al.
Disease Models & Mechanisms
|
May 18, 2026
The N-terminal region of malaria vaccine candidate Plasmodium falciparum asparagine-rich merozoite antigen is immunodominant and targeted by polyreactive antibodies
Rolando Garza, Jeffrey M Marchioni, Jared D Honeycutt, et al.
Cell Reports. Medicine
|
February 18, 2026
Transgenic mouse-derived human monoclonal antibodies targeting EBV gp350 and gp42 provide basis for therapeutic development
Crystal B Chhan, Kevin Lang, Amelia R Davis, et al.
Cell Reports
|
December 5, 2019
Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization
K Rachael Parks, Anna J MacCamy, Josephine Trichka, et al.
The Journal of Experimental Medicine
|
July 27, 2019
Anti-idiotypic antibodies elicit anti-HIV-1-specific B cell responses
Pia Dosenovic, Anna-Klara Pettersson, Abigail Wall, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 112) with videos related to
Sort By:
Page
of 12
Biorxiv : the Preprint Server for Biology
|
December 19, 2025
The N-terminal region of malaria vaccine candidate <i>Plasmodium falciparum</i> asparagine-rich merozoite antigen is immunodominant and targeted by polyreactive antibodies
Rolando Garza, Jeffrey M Marchioni, Jared D Honeycutt, et al.
Journal of Virology
|
July 12, 2013
Residue-level prediction of HIV-1 antibody epitopes based on neutralization of diverse viral strains
Gwo-Yu Chuang, Priyamvada Acharya, Stephen D Schmidt, et al.
Structure (London, England : 1993)
|
March 17, 2023
Cryo-EM structures of anti-malarial antibody L9 with circumsporozoite protein reveal trimeric L9 association and complete 27-residue epitope
Prabhanshu Tripathi, Michael F Bender, Haotian Lei, et al.
Journal of Virology
|
May 25, 2012
A short segment of the HIV-1 gp120 V1/V2 region is a major determinant of resistance to V1/V2 neutralizing antibodies
Nicole A Doria-Rose, Ivelin Georgiev, Sijy O'Dell, et al.
Cell Reports. Medicine
|
May 23, 2024
Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus
Kristina R Edwards, Karina Schmidt, Leah J Homad, et al.
Immunity
|
October 14, 2020
HIV-1 VRC01 Germline-Targeting Immunogens Select Distinct Epitope-Specific B Cell Receptors
Yu-Ru Lin, K Rachael Parks, Connor Weidle, et al.
Disease Models & Mechanisms
|
May 18, 2026
The N-terminal region of malaria vaccine candidate Plasmodium falciparum asparagine-rich merozoite antigen is immunodominant and targeted by polyreactive antibodies
Rolando Garza, Jeffrey M Marchioni, Jared D Honeycutt, et al.
Cell Reports. Medicine
|
February 18, 2026
Transgenic mouse-derived human monoclonal antibodies targeting EBV gp350 and gp42 provide basis for therapeutic development
Crystal B Chhan, Kevin Lang, Amelia R Davis, et al.
Cell Reports
|
December 5, 2019
Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization
K Rachael Parks, Anna J MacCamy, Josephine Trichka, et al.
The Journal of Experimental Medicine
|
July 27, 2019
Anti-idiotypic antibodies elicit anti-HIV-1-specific B cell responses
Pia Dosenovic, Anna-Klara Pettersson, Abigail Wall, et al.
Page
of 12